2017
DOI: 10.1002/adhm.201700196
|View full text |Cite
|
Sign up to set email alerts
|

Biomimetic Model of Tumor Microenvironment on Microfluidic Platform

Abstract: COMMUNICATION (1 of 7)© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Biomimetic Model of Tumor Microenvironment on Microfluidic PlatformMinhwan Chung, Jungho Ahn, Kyungmin Son, Sudong Kim, and Noo Li Jeon* DOI: 10.1002/adhm.201700196 "cure." [4,5] The TME is a complex, inter acting system including the tumor itself, other noncancerous cell types such as immune, stromal and endothelial cells, and the extracellular matrix surrounding these cells. [6,7] This complexity has largely prevented a comprehensive und… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
97
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 109 publications
(101 citation statements)
references
References 47 publications
0
97
0
1
Order By: Relevance
“…In a separate study, Chung et al created a biomimetic TME model that allowed for simultaneous observation of angiogenesis and lymphangiogenesis while co‐cultured with cancer cells and fibroblasts. Choi et al used a cylindrical 3‐D vessel assay that demonstrated that LSS (2 dyn/cm 2 ) selectively suppresses Notch activation in LECs but not BECs, resulting in an increase in lymphatic sprouting.…”
Section: Microfluidic Approaches For Studying Lymphatic Vasculaturementioning
confidence: 99%
“…In a separate study, Chung et al created a biomimetic TME model that allowed for simultaneous observation of angiogenesis and lymphangiogenesis while co‐cultured with cancer cells and fibroblasts. Choi et al used a cylindrical 3‐D vessel assay that demonstrated that LSS (2 dyn/cm 2 ) selectively suppresses Notch activation in LECs but not BECs, resulting in an increase in lymphatic sprouting.…”
Section: Microfluidic Approaches For Studying Lymphatic Vasculaturementioning
confidence: 99%
“…Other proteins such as fibrin have also been used as a scaffold material. Groups have utilized fibrin by itself or as a blend with different collagen percentages for various applications including cardiac, wound healing and cancer invasion studies (Chung, Ahn, Son, Kim, & Jeon, ; Lee, Park, Ryu, & Jeon, ; Mol et al, ; Nagaraju, Truong, Mouneimne, & Nikkhah, ; Purtscher, Rothbauer, Holnthoner, Redl, & Ertl, ). However, low ultimate tensile strength of this material suggests it is not well suited for tissues of high stiffness such as breast tumor microenvironments, making collagen a more desirable scaffold material (Cummings, Gawlitta, Nerem, & Stegemann, ).…”
Section: Introductionmentioning
confidence: 99%
“…Groups have utilized fibrin by itself or as a blend with different collagen percentages for various applications including cardiac, wound healing and cancer invasion studies (Chung, Ahn, Son, Kim, & Jeon, 2017;Lee, Park, Ryu, & Jeon, 2014;Mol et al, 2005;Nagaraju, Truong, Mouneimne, & Nikkhah, 2018;Purtscher, Rothbauer, Holnthoner, Redl, & Ertl, 2015).…”
mentioning
confidence: 99%
“…Several studies have shown the critical role of CAFs in cancer progression, although the mechanisms by which they promote disease progression have yet to be unraveled . Given that fibroblasts are one of the key cell populations in the stroma, a number of studies have examined tumor–fibroblast interactions on chip . Integration of microfabrication along with biomaterial‐assisted cell encapsulation can be used to compartmentalize different cell populations .…”
Section: Tumor‐on‐a‐chip Modelsmentioning
confidence: 99%